• 2017

    1) Curtis, E. M., Murray, R., Titcombe, P., Cook, E., Clarke-Harris, R., Costello, P., et al. (2017). “Perinatal DNA Methylation at CDKN2A Is Associated With Offspring Bone Mass: Findings From the Southampton Women’s Survey.” Journal of Bone and Mineral Research.

    2) Lillycrop, K., Murray, R., Cheong, C., Teh, A. L., Clarke-Harris, R., Barton, S., et al. (2017). “ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity.” EBioMedicine 19(pp 60-72).


    1) Handel, M. N., Moon, R. J., Titcombe, P., Abrahamsen, B., Heitmann, B. L., Calder, P. C., et al. (2016). “Maternal serum retinol and beta-carotene concentrations and neonatal bone mineralization: results from the Southampton Women’s Survey cohort.” American Journal of Clinical Nutrition 104(4): 1183-1188.

    2) Murray, R., Bryant, J., Titcombe, P., Barton, S. J., Inskip, H., Harvey, N. C., et al. (2016). “DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years.” Clinical Epigenetics 8(1).


    1) Menni, C., Graham, D., Kastenmuller, G., Alharbi, N. H., Alsanosi, S. M., McBride, M., et al. (2015). “Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.” Hypertension 66(2): 422-429.